Trueblood Wealth Management’s First Trust Dow Jones Global Select Dividend Index Fund FGD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Buy
106,896
+6,498
+6% +$216K 1.19% 11
2026
Q1
$3.21M Buy
100,398
+6,425
+7% +$206K 1.25% 10
2025
Q4
$2.84M Buy
93,973
+7,509
+9% +$222K 1.11% 12
2025
Q3
$2.49M Buy
86,464
+4,118
+5% +$118K 0.97% 15
2025
Q2
$2.27M Buy
82,346
+8,369
+11% +$214K 0.95% 16
2025
Q1
$1.79M Buy
73,977
+9,316
+14% +$218K 0.83% 26
2024
Q4
$1.44M Buy
64,661
+429
+0.7% +$10.1K 0.71% 35
2024
Q3
$1.56M Buy
64,232
+11,792
+22% +$276K 0.79% 30
2024
Q2
$1.17M Buy
52,440
+4,624
+10% +$106K 0.66% 41
2024
Q1
$1.09M Sell
47,816
-8,322
-15% -$184K 0.62% 47
2023
Q4
$1.25M Buy
+56,138
New +$1.18M 0.78% 33

Other funds holding FGD

Trueblood Wealth Management's FGD Position: Q2 2026 in Review

Trueblood Wealth Management increased its First Trust Dow Jones Global Select Dividend Index Fund (FGD) stake by 6.5% in Q2 2026, buying an estimated $216K and bringing the position to 106,896 shares worth $3.42M. The position accounts for 1.19% of the portfolio, ranked #11.

Trueblood Wealth Management first reported a position in FGD in Q4 2023 and has held it in 11 quarters since. 208 funds tracked by Wall St. Rank hold FGD as of Q2 2026.

  • Trueblood Wealth Management held 106,896 shares of First Trust Dow Jones Global Select Dividend Index Fund worth $3.42M as of Q2 2026.
  • Trueblood Wealth Management bought 6,498 First Trust Dow Jones Global Select Dividend Index Fund shares in Q2 2026, an estimated $216K.
  • First Trust Dow Jones Global Select Dividend Index Fund made up 1.19% of Trueblood Wealth Management's portfolio in Q2 2026, its #11 holding.
  • Trueblood Wealth Management first reported a position in First Trust Dow Jones Global Select Dividend Index Fund in Q4 2023 and has held it in 11 quarters since.
  • 208 funds tracked by Wall St. Rank held First Trust Dow Jones Global Select Dividend Index Fund as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.